Novel, orally available immune modulator MP1032 with pan-variant anti-SARS-CoV-2 and anti-inflammatory activity

Schumann S, Setz C, Schulz P, Kaiser A, Schubert U, Brysch W (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

European Journal of Immunology Wiley-VCH Verlag

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 176-177

Conference Proceedings Title: EUROPEAN JOURNAL OF IMMUNOLOGY

Authors with CRIS profile

Ulrich Schubert Professur für Virologie

Involved external institutions

MetrioPharm AG CH Switzerland (CH) ImmunoLogik GmbH DE Germany (DE)

How to cite

APA:

Schumann, S., Setz, C., Schulz, P., Kaiser, A., Schubert, U., & Brysch, W. (2022). Novel, orally available immune modulator MP1032 with pan-variant anti-SARS-CoV-2 and anti-inflammatory activity. In EUROPEAN JOURNAL OF IMMUNOLOGY (pp. 176-177). HOBOKEN: WILEY.

MLA:

Schumann, S., et al. "Novel, orally available immune modulator MP1032 with pan-variant anti-SARS-CoV-2 and anti-inflammatory activity." Proceedings of the EUROPEAN JOURNAL OF IMMUNOLOGY HOBOKEN: WILEY, 2022. 176-177.

BibTeX: Download